| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.111.025270 |
| P698 | PubMed publication ID | 21844073 |
| P50 | author | Attila Borbély | Q117260771 |
| Loek van Heerebeek | Q117260779 | ||
| Jolanda van der Velden | Q28595192 | ||
| Adelino F Leite-Moreira | Q37840717 | ||
| Cristina Gavina | Q41573286 | ||
| Ger Stienen | Q42651829 | ||
| Inês Falcão-Pires | Q52699695 | ||
| Casper G. Schalkwijk | Q76998834 | ||
| Nazha Hamdani | Q97637244 | ||
| P2093 | author name string | Walter J Paulus | |
| Hans W M Niessen | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diastole | Q492905 |
| stenosis | Q2343082 | ||
| left ventricular dysfunction | Q11755424 | ||
| ventricular dysfunction | Q54911334 | ||
| P304 | page(s) | 1151-1159 | |
| P577 | publication date | 2011-08-15 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness. | |
| P478 | volume | 124 |
| Q39310989 | A change of heart: oxidative stress in governing muscle function? |
| Q26850196 | A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation |
| Q50078700 | Abundance, localization, and functional correlates of the advanced glycation end-product carboxymethyl lysine in human myocardium. |
| Q90652972 | Alterations in Titin Properties and Myocardial Fibrosis Correlate With Clinical Phenotypes in Hemodynamic Subgroups of Severe Aortic Stenosis |
| Q37242437 | Anatomical disruption and length-tension dysfunction of anal sphincter complex muscles in women with fecal incontinence |
| Q33956080 | Anthrax lethal toxin induces acute diastolic dysfunction in rats through disruption of the phospholamban signaling network |
| Q92587591 | Aortic Stenosis Prognostication in Patients With Type 2 Diabetes: Protocol for Testing and Validation of a Biomarker-Derived Scoring System |
| Q27002459 | Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies |
| Q31132310 | Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes |
| Q38427211 | Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes |
| Q36115531 | Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement. |
| Q90402115 | Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases |
| Q24307553 | Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation |
| Q91964641 | Depressed systemic arterial compliance and impaired left ventricular midwall performance in aortic stenosis with concomitant type 2 diabetes: a retrospective cross-sectional study |
| Q38018724 | Diabetes mellitus and the heart |
| Q36479405 | Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities |
| Q59192076 | Diabetic Cardiomyopathy: Distinct and Preventable Entity or Inevitable Consequence? |
| Q26997062 | Diabetic cardiomyopathy: bench to bedside |
| Q30457504 | Diabetic cardiomyopathy: pathophysiology and clinical features |
| Q34027687 | Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity |
| Q44319013 | Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice |
| Q37153614 | Early detection of subclinical ventricular deterioration in aortic stenosis with cardiovascular magnetic resonance and echocardiography. |
| Q52654959 | Echocardiographic feature of diabetic cardiomyopathy: where are we now? |
| Q37370870 | Effect of trimetazidine treatment on the transient outward potassium current of the left ventricular myocytes of rats with streptozotocin-induced type 1 diabetes mellitus |
| Q53641091 | Excessive degradation of adenine nucleotides by up-regulated AMP deaminase underlies afterload-induced diastolic dysfunction in the type 2 diabetic heart. |
| Q35796840 | FTO Is Associated with Aortic Valve Stenosis in a Gender Specific Manner of Heterozygote Advantage: A Population-Based Case-Control Study. |
| Q47571604 | Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women? |
| Q36666891 | HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. |
| Q57180762 | Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology |
| Q41863033 | Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice |
| Q94487073 | Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study |
| Q37719325 | Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction. |
| Q48241691 | Improvement in left intraventricular pressure gradients after aortic valve replacement in aortic stenosis patients |
| Q36288050 | Incident heart failure in relation to vascular disease: insights from the Health, Aging, and Body Composition Study |
| Q55000702 | Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy. |
| Q26765931 | Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction? |
| Q54313660 | Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4. |
| Q37101896 | Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis |
| Q36392793 | Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol |
| Q51596254 | Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice. |
| Q94464153 | Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D |
| Q38038531 | Molecular and cellular basis for diastolic dysfunction |
| Q46085366 | Myoarchitectural and functional alterations in rabbit external anal sphincter muscle following experimental surgical trauma |
| Q26800076 | Myocardial hypertrophy and its role in heart failure with preserved ejection fraction |
| Q35328760 | Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin |
| Q42015211 | Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling |
| Q47122148 | Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1. |
| Q38265757 | Pathomechanisms in heart failure: the contractile connection. |
| Q39004036 | Periodontitis and myocardial hypertrophy |
| Q47168770 | Placenta-Derived Adherent Stromal Cells Improve Diabetes Mellitus-Associated Left Ventricular Diastolic Performance |
| Q93120821 | Posttranslational modifications of titin from cardiac muscle: how, where, and what for? |
| Q41573250 | Relevance of residual left ventricular hypertrophy after surgery for isolated aortic stenosis. |
| Q37116376 | Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension: Relative Contribution of Fibrosis and Myofibril Stiffness. |
| Q40749360 | Serum advanced glycation endproducts are associated with left ventricular dysfunction in normal glucose metabolism but not in type 2 diabetes: The Hoorn Study |
| Q37567574 | Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease |
| Q39310690 | Tampering with springs: phosphorylation of titin affecting the mechanical function of cardiomyocytes |
| Q37564467 | The afterload-dependent peak efficiency of the isolated working rat heart is unaffected by streptozotocin-induced diabetes. |
| Q38751389 | The associations among co-morbidity, cardiac geometries and mechanics in hospitalized heart failure with or without preserved ejection fraction. |
| Q27008079 | The molecular mechanisms of offspring effects from obese pregnancy |
| Q47093629 | Transcatheter aortic valve implantation and surgical aortic valve replacement among hospitalized patients with and without type 2 diabetes mellitus in Spain (2014-2015). |
| Q37656312 | Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). |
| Q51742440 | Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. |
| Q64086053 | Type 2 diabetes mellitus increases long-term mortality risk after isolated surgical aortic valve replacement |
Search more.